Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomerase
- 1 June 1996
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 20 (6) , 1145-1154
Abstract
Summary: The bacteriophage T4‐encoded type II DNA topoisomerase is the major target for the antitumour agent m‐AMSA (4‐(9‐acridinylamino)methanesulphon‐m‐anisidide) in phage‐infected bacterial cells. Inhibition of the purified enzyme by m‐AMSA results in formation of a cleavage complex that contains the enzyme covalently attached to DNA on both sides of a double‐strand break. In this article, we provide evidence that this cleavage complex is responsible for inhibition of phage growth and that recombinational repair can reduce sensitivity to the antitumour agent, presumably by eliminating the complex (or some derivative thereof). First, topoisomerase‐deficient mutants were shown to be resistant to m‐AMSA, indicating that m‐AMSA inhibits growth by inducing the cleavage complex rather than by inhibiting enzyme activity. Second, mutations in several phage genes that encode recombination proteins (uvsX, uvsY, 46 and 59) increased the sensitivity of phage T4 to m‐AMSA, strongly suggesting that recombination participates in the repair of topoisomerase‐mediated damage. Third, m‐AMSA stimulated recombination in phage‐infected bacterial cells, as would be expected from the recombinational repair of DNA damage. Finally, m‐AMSA induced the production of cleavage complexes involving the T4 topoisomerase within phage‐infected cells.Keywords
This publication has 48 references indexed in Scilit:
- Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase.Proceedings of the National Academy of Sciences, 1994
- Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.Proceedings of the National Academy of Sciences, 1994
- Mechanisms for gene conversion and homologous recombination: The double-strand break repair model and the successive half crossing-over modelAdvances in Biophysics, 1992
- DNA topoisomerase-trapping antitumour drugsEuropean Journal of Cancer, 1992
- UvsY protein of bacteriophage T4 is an accessory protein for in vitro catalysis of strand exchangeJournal of Molecular Biology, 1989
- Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.Proceedings of the National Academy of Sciences, 1989
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39Nucleic Acids Research, 1986
- Deoxyribonucleic acid repair in bacteriophage.Microbiological Reviews, 1981
- Nalidixic acid resistance: A second genetic character involved in DNA gyrase activityProceedings of the National Academy of Sciences, 1977